Pazoo, Inc. (PZOO) Stock Price & Analysis
Educational signal · not a buy or sell recommendation · How to read this
For informational purposes only. Not financial advice. Machine-generated analysis by Stock Expert AI — model gemini-2.0-flash, generated Mar 16, 2026. Editorial oversight is systemic, not page-by-page. Editorially accountable: Sedat ANAK, Founder and Editor-in-Chief. Data sources: Financial Modeling Prep, Yahoo Finance, SEC EDGAR
Quick AnswerPazoo, Inc. (PZOO) trades at $0.00001. Pazoo, Inc. operates as a health and wellness company, providing laboratory testing services for marijuana. Sector: Healthcare.
Price as of · Last analyzed: Mar 16, 2026Analyst Coverage for PZOO: PZOO does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage.
No score published: we hold no usable price for this ticker, and a grade beside a missing price says nothing.
Pazoo, Inc. (PZOO) Healthcare & Pipeline Overview
Pazoo, Inc. is a health and wellness company specializing in laboratory testing services for the marijuana industry. Founded in 2010 and based in East Hanover, New Jersey, Pazoo operates within the specialty and generic drug manufacturing sector, focusing on a niche market within the broader healthcare landscape.
What Is the Investment Thesis for PZOO?
Pazoo, Inc. presents a speculative investment opportunity within the niche market of marijuana testing services. The company's focus on ensuring the safety and quality of cannabis products aligns with the increasing regulatory scrutiny and consumer demand for transparency in the industry. However, with a market capitalization of $0.00B and a negative P/E ratio, the company's financial performance requires careful evaluation. The growth of the legal cannabis market serves as a primary catalyst for Pazoo, driving demand for its testing services. However, the company faces potential risks associated with intense competition, evolving regulations, and the inherent volatility of the OTC market. Investors should conduct thorough due diligence and assess Pazoo's ability to scale its operations and achieve profitability in a rapidly changing landscape.
Based on FMP financials and quantitative analysis
PZOO Key Highlights
Pazoo, Inc. operates in the health and wellness sector, specifically providing laboratory testing services for marijuana.
- The company was founded in 2010 and is headquartered in East Hanover, New Jersey.
- Pazoo, Inc. was formerly known as IUCSS, Inc. and changed its name in May 2011.
- The company's market capitalization is $0.00B.
- Pazoo, Inc. has a beta of -14.70, indicating high volatility relative to the market.
Who Are PZOO's Competitors?
PZOO is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.
| Company | Price | Change | Market Cap | MoonshotScore |
|---|---|---|---|---|
| AKAN Akanda Corp. | $1.98 | -10.41% | — | |
| SNOA Sonoma Pharmaceuticals, Inc. | $1.24 | -0.80% | $5.94M | — |
| BFRI Biofrontera Inc. | $1.01 | -2.40% | $13.0M | — |
| COSM COSM | $0.38 | -1.58% | $20.7M | — |
| QNTM Quantum BioPharma Ltd. | $3.44 | +0.44% | $22.0M | — |
| AYTU Aytu BioPharma, Inc. | $2.07 | -0.96% | $22.2M | — |
| TXMD TherapeuticsMD, Inc. | $2.05 | +0.99% | $23.7M | — |
| CPHI CPHI | $0.66 | +0.61% | $26.6M | — |
AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance
What Are PZOO's Key Strengths?
Specialized focus on marijuana testing services.
- Established presence in the cannabis industry.
- Expertise in regulatory compliance.
- Potential for growth in the expanding cannabis market.
What Are PZOO's Weaknesses?
Limited financial resources.
- Dependence on the cannabis industry.
- Small market capitalization.
- Negative P/E ratio.
What Are the Key Risks for PZOO?
Intense competition from other testing laboratories.
- Evolving regulatory landscape could impact testing requirements and costs.
- Fluctuations in the cannabis market could affect demand for testing services.
- Limited financial resources and small market capitalization.
- Dependence on the cannabis industry.
What Are PZOO's Competitive Advantages?
- Specialized expertise in marijuana testing.
- Focus on regulatory compliance.
- Established relationships with cannabis industry stakeholders.
What Does PZOO Do?
Pazoo, Inc., established in 2010, is a health and wellness company that focuses on providing laboratory testing services for the marijuana industry. Originally named IUCSS, Inc., the company rebranded as Pazoo, Inc. in May 2011, signaling a strategic shift towards the burgeoning cannabis market. Headquartered in East Hanover, New Jersey, Pazoo aims to cater to the growing demand for quality assurance and regulatory compliance within the marijuana sector. Pazoo's core business revolves around offering testing services that ensure the safety, potency, and purity of marijuana products. These services are crucial for cultivators, manufacturers, and distributors looking to meet stringent regulatory requirements and consumer expectations. By providing accurate and reliable testing, Pazoo supports the integrity of the cannabis supply chain and helps build trust among consumers. As the legal cannabis market expands across various states, Pazoo is positioned to capitalize on the increasing need for standardized testing protocols. The company's services include analyzing cannabinoid profiles, detecting contaminants such as pesticides and heavy metals, and assessing the overall quality of marijuana products. Pazoo's commitment to scientific rigor and regulatory compliance underscores its role as a key player in the evolving cannabis industry.
What Products and Services Does PZOO Offer?
- Provides laboratory testing services for marijuana.
- Ensures the safety, potency, and purity of cannabis products.
- Analyzes cannabinoid profiles.
- Detects contaminants such as pesticides and heavy metals.
- Assesses the overall quality of marijuana products.
- Supports regulatory compliance for cannabis cultivators, manufacturers, and distributors.
How Does PZOO Make Money?
- Generates revenue by charging fees for laboratory testing services.
- Offers testing services to cannabis cultivators, manufacturers, and distributors.
- Focuses on providing accurate and reliable testing results.
What Industry Does PZOO Operate In?
Pazoo, Inc. operates within the Drug Manufacturers - Specialty & Generic industry, a segment of the broader healthcare sector. The market for cannabis testing services is growing rapidly, driven by the increasing legalization of marijuana across various states and countries. This growth is fueled by the need for quality control and regulatory compliance in the cannabis industry. Pazoo faces competition from other testing laboratories and analytical service providers. The company's success depends on its ability to provide accurate, reliable, and cost-effective testing solutions to cannabis cultivators, manufacturers, and distributors.
Who Are PZOO's Key Customers?
- Cannabis cultivators
- Cannabis manufacturers
- Cannabis distributors
Research confidence
Thin evidence — scoring coverage unknown. Treat this as a starting point, not a conclusion.
- ● Scoring coverage unknown
- ● No usable price
- ● No filing on record
- ● No analyst coverage
Company Profile
Pazoo, Inc. operates in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. It is headquartered in East Hanover, US. The company is led by CEO Steven Basloe. PZOO has traded publicly since 2012.
Key Financial Metrics
Return on equity for Pazoo, Inc. stands at 48.4%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.01 means current liabilities exceed short-term assets, a liquidity point worth watching.
Financial Health
Pazoo, Inc.'s Piotroski F-Score is 4/9, a 9-point checklist of profitability, leverage and efficiency — a middling fundamental profile.
PZOO Financials
Fundamental Snapshot
Based on FMP financials and quantitative analysis
PZOO Latest News
No recent news available for PZOO.
PZOO Analyst Consensus
Consensus Rating
Aggregated Buy/Hold/Sell recommendations collected by Financial Modeling Prep for PZOO.
Price Targets
Wall Street price target analysis for PZOO.
PZOO MoonshotScore
MoonshotScore is Stock Expert AI's proprietary 0-100 research rating, not a buy or sell recommendation. No MoonshotScore is published for PZOO; grades run from A+ (80-100) to F (below 30).
Leadership: Steven Basloe
CEO
Steven Basloe serves as the CEO of Pazoo, Inc. Further research would be required to provide a comprehensive profile of Mr. Basloe's professional background and qualifications.
Track Record: Due to the limited information available, it is not possible to assess Steven Basloe's track record at Pazoo, Inc. Key achievements, strategic decisions, and company milestones under his leadership cannot be determined without additional data.
PZOO OTC Market Information
The OTC Other tier represents the lowest tier of the OTC market, encompassing stocks that may not meet the minimum financial standards or have chosen not to comply with the reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier often have limited information available to investors and may be subject to less regulatory oversight compared to those listed on major exchanges like the NYSE or NASDAQ. Investing in OTC Other stocks carries a higher degree of risk due to the potential for fraud, lack of transparency, and limited liquidity.
- OTC Tier: OTC Other
- Limited financial disclosure and transparency.
- Potential for fraud and market manipulation.
- High price volatility due to low trading volume.
- Limited liquidity, making it difficult to buy or sell shares.
- Lack of regulatory oversight compared to major exchanges.
- Verify the company's registration and legal standing.
- Obtain and review any available financial statements.
- Assess the company's business model and competitive landscape.
- Evaluate the management team's experience and track record.
- Understand the risks associated with investing in OTC stocks.
- Consult with a financial advisor before making any investment decisions.
- Company has been in operation since 2010.
- Focuses on laboratory testing services for the marijuana industry, which aligns with a growing market.
- Headquartered in East Hanover, New Jersey.
Common Questions About PZOO (Healthcare)
What do analysts say about PZOO stock?
There is no available analyst coverage or consensus on PZOO stock due to its OTC listing and limited market capitalization. Key valuation metrics such as price targets and earnings estimates are not readily available.
Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.
Official Resources
MoonshotScore is not published for this security.
Data provided for informational purposes only.
- Limited financial data available for Pazoo, Inc.
- OTC market investments carry higher risk.